BALAXI.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 03:25):

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana...

Stats
Today's Volume	5 798.00
Average Volume	15 493.00
Market Cap	6.66B
EPS	INR14.06 ( 2023-09-30 )
Last Dividend	INR0.500 ( 2022-07-01 )
Next Dividend	INR0 ( N/A )
P/E	-116.37
ATR14	INR3.07 (0.51%)

Volume Correlation

Long: 0.21 (neutral)

Short: 0.80 (strong)

Signal:(46.929) Same movement expected

Balaxi Pharmaceuticals Correlation

10 Most Positive Correlations
LAKSHVILAS.NS	0.837
ASIANPAINT.NS	0.829
KIRIINDUS.NS	0.822
BGLOBAL.NS	0.819
DIXON.NS	0.802
DMART.NS	0.801

10 Most Negative Correlations
DFMFOODS.NS	-0.833
TOUCHWOOD.NS	-0.827

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Balaxi Pharmaceuticals Correlation - Currency/Commodity

0.38
( neutral )

0.55
( weak )

0.01
( neutral )

-0.15
( neutral )

0.67
( moderate )

-0.71
( moderate negative )

Balaxi Pharmaceuticals Financials

Annual	2022
Revenue:	INR3.36B
Gross Profit:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Revenue:	INR3.36B
Gross Profit:	INR1.34B (39.83 %)
EPS:	INR45.81

FY	2022
Revenue:	INR2.79B
Gross Profit:	INR837.92M (29.99 %)
EPS:	INR47.66

FY	2021
Revenue:	INR2.31B
Gross Profit:	INR591.85M (25.58 %)
EPS:	INR38.14

Financial Reports:

No articles found.

Balaxi Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Balaxi Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 2.50 - low (50.00%) | Divividend Growth Potential Score: 0.0536 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2022-07-01
Last Dividend	INR0.500	2022-07-01
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR0.500	--
Avg. Dividend % Per Year	0.02%	--
Score	0.4	--
Div. Sustainability Score	2.50
Div.Growth Potential Score	0.0536
Div. Directional Score	1.279	--

Next Divdend (Est)
(2024-05-09)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.40

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2022	INR0.500	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SESHAPAPER.NS	Dividend Knight	2023-06-07	Annually	23	1.14%
MALLCOM.NS	Dividend Junior	2023-09-04	Annually	3	0.20%
GOKEX.NS	Dividend Junior	2023-09-13	Sporadic	20	0.07%
AUTOAXLES.NS	Dividend Junior	2023-07-27	Annually	22	0.72%
TRIL.NS	Dividend Junior	2023-07-27	Sporadic	17	0.22%
PIIND.NS	Dividend Knight	2023-08-10	Semi-Annually	14	0.18%
JINDRILL.NS	Dividend Junior	2023-08-14	Annually	18	0.23%
DELTACORP.NS	Dividend Junior	2023-07-07	Annually	17	0.39%
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0199	1.500	-0.398	-0.597	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0309	1.500	-1.454	-2.18	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	31.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.82	2.00	8.09	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.424	1.000	6.26	6.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.161	1.000	8.77	8.77	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-117.54	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0309	2.50	-0.935	-2.18	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.82	2.00	8.73	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0149	1.000	-2.13	0	[0.1 - 0.5]
Total Score				0.0536

Balaxi Pharmaceuticals

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.